start portlet menu bar end portlet menu bar

Comparative study of the safety of 3 trivalent inactivated vaccines against Swine Erysipelas, Porcine Parvovirus and Leptospira in gilts

Home Kennis Comparative study of the safety of 3 trivalent inactivated vaccines against Swine Erysipelas, Porcine Parvovirus and Leptospira in gilts

Comparative study of the safety of 3 trivalent inactivated vaccines against Swine Erysipelas, Porcine Parvovirus and Leptospira in gilts

The aim of this study was to compare the safety of 3 different commercial trivalent vaccines against these reproductive diseases in sows.

Download dit artikel

348 kB

Over dit artikel

Gepubliceerd in

APVS Congress, 2017

Datum

12 mei 2017

Auteurs

Boix, O.; Camprodon, A.; Sánchez-Matamoros, A.

Samenvatting

Results clearly show the optimum performance obtained with ERYSENG® PARVO/LEPTO vaccine, which achieved better safety levels than its competitors. These differences may trigger lower feed intake by the sow, affect the sow’s milk production and consequently result in a lower weight gain by the piglets.

Gerelateerde diensten

HIPRAlink® Diagnos

HIPRA Diagnos

Gerelateerde producten

ERYSENG® PARVO/LEPTO

Gerelateerde publicaties

Assessment of the safety of ERYSENG® PARVO compared to a trivalent vaccine Assessment of the humoral immune response against swine erysipelas Assessment of the efficacy of ERYSENG® PARVO/LEPTO in Thailand

Delen

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}
start portlet menu bar end portlet menu bar

Zie ook

Publicaties

Assessment of the safety of ERYSENG® PARVO compared to a trivalent vaccine

10-11-2020
Omschrijving ziekte

Let's Talk about SOW MORTALITY

29-06-2021
Nieuws

We have evolved to be stronger

23-06-2021